Greenwich LifeSciences (GLSI) Interest Coverage Ratio (2019 - 2025)
Greenwich LifeSciences (GLSI) posted Interest Coverage Ratio of 0.86 for Q4 2025, up 41.43% on a QoQ basis from 1.46 in Q4 2024, and up 41.43% year-over-year from 0.61 in Q4 2024.
Greenwich LifeSciences (GLSI) Interest Coverage Ratio (2019 - 2025) Analysis & Trends
Greenwich LifeSciences' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 0.86 for Q4 2025.
- Quarterly Interest Coverage Ratio rose 41.43% year-over-year to 0.86 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 2.1 (up 21.08% YoY) and the FY2025 annual result came in at 2.1, up 21.08% from the prior year.
- Interest Coverage Ratio was 0.86 for Q4 2025 at Greenwich LifeSciences, up from 1.46 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.42 in Q2 2022 and bottomed at 1.57 in Q4 2021.
- A 5-year average of 1.03 and a median of 1.05 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio slumped 132.33% — and 2025, when it jumped 41.43%.
- Greenwich LifeSciences' Interest Coverage Ratio stood at 1.57 in 2021, then soared by 41.23% to 0.92 in 2022, then jumped by 31.77% to 0.63 in 2023, then slumped by 132.33% to 1.46 in 2024, then soared by 41.43% to 0.86 in 2025.
- Business Quant data shows GLSI's Interest Coverage Ratio at 0.86 in Q4 2025, 1.46 in Q4 2024, and 0.63 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Greenwich LifeSciences | 178.53 Mn | 178.53 Mn | - | -0.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.86 |
| Dec 31, 2024 | -1.46 |
| Dec 31, 2023 | -0.63 |
| Dec 31, 2022 | -0.92 |
| Sep 30, 2022 | -1.19 |
| Jun 30, 2022 | -0.42 |
| Mar 31, 2022 | -1.18 |
| Dec 31, 2021 | -1.57 |
| Dec 31, 2020 | -1.11 |
| Dec 31, 2019 | -0.43 |